A carregar...
Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension
BACKGROUND: Droxidopa, a prodrug of norepinephrine, was approved for treatment of neurogenic orthostatic hypotension (nOH) due to primary autonomic disorders based on 3 randomized double-blind studies. We performed safety and efficacy analyses of this pooled dataset (n = 460). METHODS: Efficacy was...
Na minha lista:
| Publicado no: | BMC Neurol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5427571/ https://ncbi.nlm.nih.gov/pubmed/28494751 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-017-0867-5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|